Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Jazz Pharmaceuticals plcJAZZ · Entity 818 | SVP, Europe & Rest of World | March 05, 2019 | March 08, 2019 |
| OTONOMY, INC.OTIC · Entity 116495 | Director | June 21, 2022 | June 23, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Jazz Pharmaceuticals plc
Report date March 05, 2019 · Filed March 08, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 24,938 |
Ending reported balance
After 2019-03-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2019-03-05 · Tax withholding · Disposed 549 · Balance 25,556 F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Row 2 · 2019-03-05 · Tax withholding · Disposed 618 · Balance 24,938 F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
OTONOMY, INC.
Report date June 21, 2022 · Filed June 23, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.95 · Expires 2032-06-20 | Direct | 27,500 |
Reported balance
After 2022-06-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-21 · Grant · Acquired 27,500 · Balance 27,500 F1: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date, and (ii) the date of the Issuer's next annual meeting of stockholders occurring after the grant date, provided that the Reporting Person remains a service provider through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date, and (ii) the date of the Issuer's next annual meeting of stockholders occurring after the grant date, provided that the Reporting Person remains a service provider through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 21, 2022 Filed Jun 23, 2022 16:34 UTC | OTONOMY, INC. OTIC · Entity 116495 | GrantStock Option (right to buy) · Derivative | 27,500 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001209191-22-038891 · doc4.xml · derivative · entry 1 McGill Iain · CIK 0001615764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 27,500 shares Expires 2032-06-20 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date, and (ii) the date of the Issuer's next annual meeting of stockholders occurring after the grant date, provided that the Reporting Person remains a service provider through such date. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 17:03 UTC | OTONOMY, INC. OTIC · Entity 116495 | GrantStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001209191-21-043074 · doc4.xml · derivative · entry 1 McGill Iain · CIK 0001615764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2031-06-21 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date, and (ii) the date of the Issuer's next annual meeting of stockholders occurring after the grant date, provided that the Reporting Person remains a service provider through such date. Read SEC document |
| June 23, 2020 Filed Jun 25, 2020 17:07 UTC | OTONOMY, INC. OTIC · Entity 116495 | GrantStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $3.56 | $0.00 |
DisclosureSEC source: 0001209191-20-038944 · doc4.xml · derivative · entry 1 McGill Iain · CIK 0001615764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2030-06-22 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the earlier of (i) the one year anniversary of the grant date, and (ii) the date of the Issuer's next annual meeting of stockholders occurring after the grant date, provided that the Reporting Person remains a service provider through such date. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 17:06 UTC | OTONOMY, INC. OTIC · Entity 116495 | GrantStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001209191-19-036840 · doc4.xml · derivative · entry 1 McGill Iain · CIK 0001615764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2029-06-10 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the date of the Issuer's next annual meeting of stockholders occurring after the grant date, provided that the Reporting Person remains a service provider through such date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 00:06 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 618 | $135.82 | $83,936.76 |
DisclosureSEC source: 0001765581-19-000035 · edgardoc.xml · nonDerivative · entry 2 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,938 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 00:06 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 549 | $135.82 | $74,565.18 |
DisclosureSEC source: 0001765581-19-000035 · edgardoc.xml · nonDerivative · entry 1 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,556 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 00:34 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $140.03 | $0.00 |
DisclosureSEC source: 0001765581-19-000019 · edgardoc.xml · derivative · entry 2 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Ordinary Shares · 12,500 shares Expires 2029-02-27 F2 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 28, 2019, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. Read SEC document |
| February 28, 2019 Filed Mar 5, 2019 00:34 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-19-000019 · edgardoc.xml · nonDerivative · entry 1 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,105 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years. Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 23:36 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 394 | $127.76 | $50,337.44 |
DisclosureSEC source: 0001765581-19-000006 · edgardoc.xml · nonDerivative · entry 2 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,105 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| February 25, 2019 Filed Feb 27, 2019 23:36 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 549 | $126.25 | $69,311.25 |
DisclosureSEC source: 0001765581-19-000006 · edgardoc.xml · nonDerivative · entry 1 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,499 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 19:38 UTC | OTONOMY, INC. OTIC · Entity 116495 | GrantStock Option (right to buy) · Derivative | 17,500 | $0.00 Strike: $4.45 | $0.00 |
DisclosureSEC source: 0001209191-18-038877 · doc4.xml · derivative · entry 1 McGill Iain · CIK 0001615764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2028-06-18 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest upon the date of the Issuer's next annual meeting of stockholders occurring after the grant date, provided that the Reporting Person remains a service provider through such date. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 21:12 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 614 | $143.39 | $88,041.46 |
DisclosureSEC source: 0001232524-18-000064 · edgardoc.xml · nonDerivative · entry 1 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,048 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:28 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $140.67 | $0.00 |
DisclosureSEC source: 0001232524-18-000044 · edgardoc.xml · derivative · entry 2 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires 2028-02-29 F2 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 1, 2018, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:28 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001232524-18-000044 · edgardoc.xml · nonDerivative · entry 1 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,662 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2018, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 22:25 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 784 | $143.80 | $112,739.20 |
DisclosureSEC source: 0001232524-18-000027 · edgardoc.xml · nonDerivative · entry 2 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,662 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 22:25 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 937 | $147.44 | $138,151.28 |
DisclosureSEC source: 0001232524-18-000027 · edgardoc.xml · nonDerivative · entry 1 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,446 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 22:29 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 8,000 | $133.42 Strike: $46.83 | $1,067,357.60 |
DisclosureSEC source: 0001232524-17-000183 · edgardoc.xml · derivative · entry 3 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Underlying: Ordinary Shares · 8,000 shares Expires 2022-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This non-qualified stock option was granted on August 9, 2012 and vested over a period four years from date of grant. The options were fully vested as of August 9, 2016. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 22:29 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | SaleOrdinary Shares | 8,000 | $133.42 | $1,067,357.60 |
DisclosureSEC source: 0001232524-17-000183 · edgardoc.xml · nonDerivative · entry 2 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,383 F1 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $132.95 to $133.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| November 17, 2017 Filed Nov 21, 2017 22:29 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Exercise / conversionOrdinary Shares | 8,000 | $46.83 | $374,640.00 |
DisclosureSEC source: 0001232524-17-000183 · edgardoc.xml · nonDerivative · entry 1 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,383 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 20, 2017 Filed Jul 14, 2017 18:32 UTC | OTONOMY, INC. OTIC · Entity 116495 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $16.05 | $0.00 |
DisclosureSEC source: 0001209191-17-045253 · doc4.xml · derivative · entry 1 McGill Iain · CIK 0001615764 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-20 F1 · derivative.exercise_date: The shares subject to the option vest in full on the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| March 06, 2017 Filed Mar 8, 2017 22:37 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 818 | $132.81 | $108,638.58 |
DisclosureSEC source: 0001232524-17-000071 · edgardoc.xml · nonDerivative · entry 1 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,383 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 23:51 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 11,250 | $0.00 Strike: $136.18 | $0.00 |
DisclosureSEC source: 0001232524-17-000059 · edgardoc.xml · derivative · entry 2 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Ordinary Shares · 11,250 shares Expires 2027-03-01 F2 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, March 2, 2017, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 23:51 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | GrantOrdinary Shares | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001232524-17-000059 · edgardoc.xml · nonDerivative · entry 1 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,201 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2017, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:13 UTC | Jazz Pharmaceuticals plc JAZZ · Entity 818 | Tax withholdingOrdinary Shares | 1,721 | $136.97 | $235,725.37 |
DisclosureSEC source: 0001232524-17-000035 · edgardoc.xml · nonDerivative · entry 1 McGill Iain · CIK 0001615764 · SVP, Europe & Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,701 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.